Metabolites profiling and pharmacokinetics of troxipide and its pharmacodynamics in rats with gastric ulcer.
Ontology highlight
ABSTRACT: Troxipide is widely used to treat gastric ulcer (GU) in the clinic. However, a lack of systematic metabolic, pharmacokinetic and pharmacological studies limits its clinical use. This study aimed to firstly explore the metabolic, pharmacokinetic and pharmacological mechanisms of troxipide in rats with GU compared to normal control (NC) rats. First, metabolic study was perormed by a highly selective, high-resolution mass spectrometry method. A total of 45 metabolites, including 9 phase I metabolites and 36 phase II metabolites, were identified based on MS/MS spectra. Subsequently, the pharmacokinetics results suggested that the Cmax, Ka, t1/2, AUC(0-t) and AUC(0-∞) of troxipide were significantly increased in rats with GU compared with N
SUBMITTER: Guo H
PROVIDER: S-EPMC7423950 | biostudies-literature | 2020 Aug
REPOSITORIES: biostudies-literature
ACCESS DATA